BRAUN STACEY ASSOCIATES INC Halozyme Therapeutics, Inc. Transaction History

BRAUN STACEY ASSOCIATES INC portfolio value:

$10.16M
portfolio value

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 257.12K shares 10.16M $39.54 257.12K